SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Dycom delivered record first quarter results with $1.965B in contract revenues, up 56.1%, and adjusted EPS of $4.42, exceeding guidance while announcing the acquisition of National…
Dick's Sporting Goods reported Q1 earnings of $3.54 per share with 6% comparable sales growth in its core business, while the Foot Locker acquisition returned to profitability and …
IMMUNIC, INC. has entered into an employment agreement with Erik Lundgren to serve as CEO effective May 22, 2026. The appointment represents a leadership change for the biopharmace…
Capri Holdings reported Q4 FY2026 results showing return to profitability with strategic initiatives for Michael Kors and Jimmy Choo gaining traction. The company provided FY2027 g…
Apogee Therapeutics announced a strategic financing collaboration with Blackstone Life Sciences providing up to $1.3 billion in non-dilutive capital, including $800 million in synt…
Apogee announced positive 16-week Part B induction dose optimization results from its Phase 2 APEX trial of zumilokibart, with 65.9% of mid-dose patients achieving EASI-75 endpoint…
Nano Dimension agreed to sell its MarkForged subsidiary to Stratasys for $42.5 million in an all-cash transaction expected to close in H2 2026. The sale is expected to reduce Nano …
Streamex Corp. announced the appointment of Kori Handy as Vice President of Product and Design, bringing 18 years of fintech and SaaS experience from companies including Microsoft,…
Lumen Technologies filed amended and restated articles of incorporation detailing authorized capital structure of 2.2 billion common shares and 2 million preferred shares. The fili…
Artificial Intelligence Technology Solutions' RAD subsidiary converted a 30-day retail security pilot into a long-term recurring revenue agreement for two ROSA devices with plans f…
# FDA Approves ANDA for Somerset Therapeutics Somerset Therapeutics LLC has received FDA approval for an abbreviated new drug application (ANDA219529), expanding its generic drug …
Camber Pharmaceuticals Inc. won final FDA approval Tuesday for its generic 25-mg losartan potassium and hydrochlorothiazide tablets, completing a process that has allowed other gen…
Data Storage Corporation entered into an equity distribution agreement with Maxim Group LLC to sell authorized but unissued common stock as a sales agent. The agreement provides th…
BCPC I, LLC requested and received a new $50 million commitment under its credit agreement with Goldman Sachs Bank USA, effective May 21, 2026. The increase expands the borrower's …
Rani Therapeutics Holdings filed warrant documentation allowing holders to purchase Class A Common Stock at a specified exercise price starting from the original issue date. The of…
News Corporation filed an ASX notification for a buyback program authorizing repurchases of up to $1 billion in Class A common stock. The program represents a capital allocation in…
Michael Gillespie & Associates, PLLC has confirmed agreement with Goldenwell Biotech's statements regarding auditor changes filed on May 26, 2026. This auditor acknowledgment lette…
Solo Brands adopted an amended and restated 2021 incentive award plan to enhance recruitment and retention through expanded equity ownership opportunities for service providers. Th…
Apollo Asset Backed Credit Co LLC disclosed its monthly net asset value of $1.882 billion across 73.5 million outstanding shares, with NAV per share ranging from $24.97 to $25.84 d…
Five9 filed a restated certificate of incorporation dated May 20, 2026. This is a routine corporate governance filing with no material operational impact.